The 2010 NICE COPD guidelines: How do they compare with the GOLD guidelines

Primary Care Respiratory Journal

Volumn 20, Issue 2, 2011, Pages 199-204

  Gruffydd Jonesa, Kevin ^a   Loveridgeb, Chris ^b  

^a General Practitioner   (United Kingdom)

^b Education For Health   (United Kingdom)

Author keywords

COPD; Diagnosis; GOLD; Guidelines; Management; NICE; Pharmacotherapy; Primary care

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; LONG ACTING DRUG; MUSCARINIC RECEPTOR BLOCKING AGENT; SALBUTAMOL; SHORT ACTING DRUG; TIOTROPIUM BROMIDE;

AIRWAY OBSTRUCTION; ALGORITHM; ARTICLE; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DOSAGE SCHEDULE COMPARISON; DRUG COST; DRUG PREFERENCE; DRUG TOLERABILITY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MONOTHERAPY; PRACTICE GUIDELINE; PULMONARY REHABILITATION; RECOMMENDED DRUG DOSE; SYMPTOM; UNITED KINGDOM;

DIAGNOSTIC TECHNIQUES, RESPIRATORY SYSTEM; DISEASE MANAGEMENT; GREAT BRITAIN; HUMANS; PRACTICE GUIDELINES AS TOPIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 79957927594     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2011.00011     Document Type: Article

References (16)

1. Global Strategy for the Diagnosis, Management and prevention of Chronic Obstructive Pulmonary Disease 2009. Global Initiative for Chronic obstructive Lung Disease (GOLD) www.goldcopd.com
2. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356(8):775-89. http://dx.doi.org/10.1056/NEJMoa063070
3. Calverley P, Pauwels R, Vestbo J, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomized controlled trial. Lancet 2003;361(9356):449-456. http://dx.doi.org/10.1016/S0140-6736(03)12459-2
4. Szafranski W, Cukier A, Ramirez A, et al. Efficacy and safety of budesonide/ formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J 2003;21(1):74-81. http://dx.doi.org/10.1183/09031936.03.00031402
5. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators. A 4 year trial of Tiotropium in chronic obstructive pulmonary disease. New Eng J Med 2008;359(15):1543-1554. http://dx.doi.org/10.1056/NEJMoa0805800
6. National Clinical Guideline Centre. (2010) Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. London: National Clinical Guideline Centre.
7. Pearson M. Chronic obstructive Pulmonary Disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004;59(Suppl 1):1-232
8. Global Strategy for the Diagnosis, Management and prevention of Chronic Obstructive Pulmonary Disease 2007. Global Initiative for Chronic Obstructive Lung Disease (GOLD) www.goldcopd.com
9. Guyatt GH, Oxman AD, Vist GE, et al. GRADE - an emerging consensus on quality of evidence on strength of recommendations. BMJ 2008;336:924-6. http://dx.doi.org/10.1136/bmj.39489.470347.AD
10. The Quality and Outcomes Framework (QOF) www.ic.nhs.uk
11. Levy ML, Quanjer PH, Booker R, Cooper BG, Holmes S, Small, IR. Diagnostic Spirometry in Primary Care. Proposed Standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendations. Prim Care Respir J 2009;18(3):130-147. http://dx.doi.org/10.4104/pcrj.2009.00054
12. Celli BR, Cote CG, Marin JM, et al. The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease. NEJM 2004;350:1005-12. http://dx.doi.org/10.1056/NEJMoa021322
13. Jones RC, Donaldson GC, Chavannes NH, et al. Derivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the DOSE Index. Am J Respir Crit Care Med 2009;180:1189-1195. http://dx.doi.org/10.1164/rccm.200902-0271OC
14. Van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003;1:13. http://dx.doi.org/10.1186/1477-7525-1-13
15. Jones PW, Harding G, Berry P, et al. The COPD Assessment Tool (CAT) www.catestonline.org. Development and first validation of the COPD Assessment Test. Eur Respir J 2009;34(3):648-654.
16. Diagnosis and Management of COPD in Primary Care. Primary Care Respiratory Society (UK) 2010 www.pcrs-uk.org